drugset / Trial / NCT00045123

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

NCT00045123 ↗

Phase 2 Unknown Myrexis Inc.
RandomizedDouble-blindTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. R-flurbiprofen may be effective in delaying the recurrence of localized prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of R-flurbiprofen in treating patients who have localized prostate cancer at risk of recurrence following radiation therapy and/or prostatectomy.

Timeline

Start
2002-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject tarenflurbil Small molecule — Oral

Indications